Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glutamine-tRNA ligase activity	LARS1 QARS1	9.18e-06	2	61	2	GO:0004819
GeneOntologyBiologicalProcess	glutaminyl-tRNA aminoacylation	LARS1 QARS1	8.60e-06	2	61	2	GO:0006425
Domain	BMP3/BMP3B	BMP3 GDF10	1.01e-05	2	60	2	IPR017197
Domain	Kringle-like	KREMEN1 LPA ELSPBP1	1.46e-04	32	60	3	IPR013806
Domain	CUB	KREMEN1 ATRNL1 ADGRG6	5.23e-04	49	60	3	PF00431
Domain	CUB	KREMEN1 ATRNL1 ADGRG6	5.55e-04	50	60	3	SM00042
Domain	-	KREMEN1 ATRNL1 ADGRG6	6.23e-04	52	60	3	2.60.120.290
Domain	CUB	KREMEN1 ATRNL1 ADGRG6	6.59e-04	53	60	3	PS01180
Domain	CUB_dom	KREMEN1 ATRNL1 ADGRG6	8.15e-04	57	60	3	IPR000859
Domain	Kringle	KREMEN1 LPA	1.34e-03	17	60	2	IPR000001
Domain	Kringle_CS	KREMEN1 LPA	1.34e-03	17	60	2	IPR018056
Domain	KRINGLE_2	KREMEN1 LPA	1.34e-03	17	60	2	PS50070
Domain	Kringle	KREMEN1 LPA	1.34e-03	17	60	2	PF00051
Domain	KRINGLE_1	KREMEN1 LPA	1.34e-03	17	60	2	PS00021
Domain	KR	KREMEN1 LPA	1.34e-03	17	60	2	SM00130
Domain	aa-tRNA-synth_I_CS	LARS1 QARS1	1.50e-03	18	60	2	IPR001412
Domain	AA_TRNA_LIGASE_I	LARS1 QARS1	1.68e-03	19	60	2	PS00178
Domain	UDPGT	UGT2B15 UGT2B17	2.05e-03	21	60	2	PF00201
Domain	UDPGT	UGT2B15 UGT2B17	2.05e-03	21	60	2	PS00375
Domain	UDP_glucos_trans	UGT2B15 UGT2B17	2.05e-03	21	60	2	IPR002213
Domain	Lectin_C	CLEC5A ATRNL1 KLRF2	2.50e-03	84	60	3	PF00059
Domain	CLECT	CLEC5A ATRNL1 KLRF2	2.50e-03	84	60	3	SM00034
Domain	C_TYPE_LECTIN_2	CLEC5A ATRNL1 KLRF2	2.58e-03	85	60	3	PS50041
Domain	C-type_lectin-like	CLEC5A ATRNL1 KLRF2	2.67e-03	86	60	3	IPR001304
Domain	TGFb_propeptide	BMP3 GDF10	3.64e-03	28	60	2	PF00688
Domain	TGF-b_N	BMP3 GDF10	3.64e-03	28	60	2	IPR001111
Domain	-	CLEC5A ATRNL1 KLRF2	3.75e-03	97	60	3	3.10.100.10
Domain	C-type_lectin-like/link	CLEC5A ATRNL1 KLRF2	3.97e-03	99	60	3	IPR016186
Domain	TGF-beta-rel	BMP3 GDF10	4.73e-03	32	60	2	IPR015615
Domain	TGFb_CS	BMP3 GDF10	4.73e-03	32	60	2	IPR017948
Domain	CTDL_fold	CLEC5A ATRNL1 KLRF2	4.94e-03	107	60	3	IPR016187
Domain	TGFB	BMP3 GDF10	6.29e-03	37	60	2	SM00204
Domain	TGF-b_C	BMP3 GDF10	6.29e-03	37	60	2	IPR001839
Domain	TGF_BETA_2	BMP3 GDF10	6.29e-03	37	60	2	PS51362
Domain	TGF_beta	BMP3 GDF10	6.29e-03	37	60	2	PF00019
Domain	TGF_BETA_1	BMP3 GDF10	6.29e-03	37	60	2	PS00250
Domain	Rossmann-like_a/b/a_fold	LARS1 QARS1	8.42e-03	43	60	2	IPR014729
Domain	-	LARS1 QARS1	8.42e-03	43	60	2	3.40.50.620
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	3.03e-06	2	61	2	24267955
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	3.03e-06	2	61	2	22170718
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	3.03e-06	2	61	2	32660355
Pubmed	The crystal structure of human GlnRS provides basis for the development of neurological disorders.	LARS1 QARS1	3.03e-06	2	61	2	26869582
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	3.03e-06	2	61	2	3105095
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	3.03e-06	2	61	2	17848572
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	3.03e-06	2	61	2	27496708
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	3.03e-06	2	61	2	1909870
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	3.03e-06	2	61	2	28228532
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	3.03e-06	2	61	2	24121496
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	3.03e-06	2	61	2	15666817
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	3.03e-06	2	61	2	3117546
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	3.03e-06	2	61	2	17698910
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	9.07e-06	3	61	2	19572376
Pubmed	Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.	UGT2B15 UGT2B17	9.07e-06	3	61	2	26163549
Pubmed	Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.	UGT2B15 UGT2B17	9.07e-06	3	61	2	17988216
Pubmed	Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.	UGT2B15 UGT2B17	9.07e-06	3	61	2	20736324
Pubmed	Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.	UGT2B15 UGT2B17	9.07e-06	3	61	2	23223495
Pubmed	Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.	UGT2B15 UGT2B17	9.07e-06	3	61	2	26385605
Pubmed	Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.	UGT2B15 UGT2B17	9.07e-06	3	61	2	18302198
Pubmed	Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.	UGT2B15 UGT2B17	9.07e-06	3	61	2	28882566
Pubmed	The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.	UGT2B15 UGT2B17	9.07e-06	3	61	2	30689982
Pubmed	A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.	LPA F13A1	1.81e-05	4	61	2	32315384
Pubmed	Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.	UGT2B15 UGT2B17	1.81e-05	4	61	2	18281521
Pubmed	Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.	UGT2B15 UGT2B17	1.81e-05	4	61	2	26176234
Pubmed	Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.	UGT2B15 UGT2B17	4.52e-05	6	61	2	21365123
Pubmed	Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.	LPA F13A1	4.52e-05	6	61	2	31101623
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B15 UGT2B17	6.32e-05	7	61	2	26074487
Pubmed	Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination.	ZFAT NUP160 F13A1	7.88e-05	47	61	3	26687681
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT2B15 UGT2B17	8.42e-05	8	61	2	22579593
Pubmed	Structural analysis of the high molecular mass aminoacyl-tRNA synthetase complex. Effects of neutral salts and detergents.	LARS1 QARS1	8.42e-05	8	61	2	1651330
Pubmed	Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases.	LARS1 QARS1	8.42e-05	8	61	2	10913161
Pubmed	Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1.	LARS1 QARS1	8.42e-05	8	61	2	36347866
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B15 UGT2B17	8.42e-05	8	61	2	32093886
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT2B15 UGT2B17	8.42e-05	8	61	2	18719240
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT2B15 UGT2B17	8.42e-05	8	61	2	20142249
Pubmed	Identification of host proteins required for HIV infection through a functional genomic screen.	FLII USP6 PPP2R2A LARS1 NUP160	1.17e-04	272	61	5	18187620
Pubmed	The human EPRS locus (formerly the QARS locus): a gene encoding a class I and a class II aminoacyl-tRNA synthetase.	LARS1 QARS1	1.35e-04	10	61	2	8188258
Pubmed	The C-terminal appended domain of human cytosolic leucyl-tRNA synthetase is indispensable in its interaction with arginyl-tRNA synthetase in the multi-tRNA synthetase complex.	LARS1 QARS1	1.35e-04	10	61	2	16055448
Pubmed	The appended C-domain of human methionyl-tRNA synthetase has a tRNA-sequestering function.	LARS1 QARS1	1.35e-04	10	61	2	11714285
Pubmed	Human cytoplasmic isoleucyl-tRNA synthetase: selective divergence of the anticodon-binding domain and acquisition of a new structural unit.	LARS1 QARS1	1.35e-04	10	61	2	8052601
Pubmed	Evolution of the Glx-tRNA synthetase family: the glutaminyl enzyme as a case of horizontal gene transfer.	LARS1 QARS1	1.35e-04	10	61	2	8078941
Pubmed	Human lysyl-tRNA synthetase accepts nucleotide 73 variants and rescues Escherichia coli double-defective mutant.	LARS1 QARS1	1.35e-04	10	61	2	9278442
Pubmed	Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells.	LARS1 QARS1	1.65e-04	11	61	2	19289464
Pubmed	Expression of human aspartyl-tRNA synthetase in Escherichia coli. Functional analysis of the N-terminal putative amphiphilic helix.	LARS1 QARS1	1.65e-04	11	61	2	8449960
Pubmed	Dissection of the structural organization of the aminoacyl-tRNA synthetase complex.	LARS1 QARS1	1.65e-04	11	61	2	19131329
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT2B15 UGT2B17	1.97e-04	12	61	2	20308471
Pubmed	Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein.	LARS1 QARS1	2.33e-04	13	61	2	9878398
Pubmed	Deletion of Lrp4 increases the incidence of microphthalmia.	BMP3 GDF10 SMAD9	2.48e-04	69	61	3	30352686
Pubmed	p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance.	LARS1 QARS1	2.72e-04	14	61	2	12060739
Pubmed	A molecular analysis of matrix remodeling and angiogenesis during long bone development.	BMP3 TIMP3	4.05e-04	17	61	2	11165481
Pubmed	Gene essentiality and synthetic lethality in haploid human cells.	PPP2R2A ZFAT LARS1 QARS1	7.12e-04	229	61	4	26472760
Pubmed	Fras1, a basement membrane-associated protein mutated in Fraser syndrome, mediates both the initiation of the mammalian kidney and the integrity of renal glomeruli.	FRAS1 SMAD9	7.48e-04	23	61	2	18787044
Pubmed	Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genes.	VPS35L F13A1	7.48e-04	23	61	2	20532202
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	GPR83 FRAS1 ZFAT	8.01e-04	103	61	3	10819331
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	PPP2R2A ELMO2 BCR	8.01e-04	103	61	3	21706016
Pubmed	Identification of novel markers of mouse fetal ovary development.	LYPD6 CAMKMT	9.57e-04	26	61	2	22844512
Pubmed	BMP4 and Wnt signaling interact to promote mouse tracheal mesenchyme morphogenesis.	BMP3 SMAD9	9.57e-04	26	61	2	34851738
Pubmed	The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage.	GDF10 SMAD9	9.57e-04	26	61	2	31311865
Pubmed	Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.	TMEM11 FLII	1.03e-03	27	61	2	17273973
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PPP2R2A ZNF33A MYO9A CLK2 VPS35L CAMKMT BCR ZRANB1 ADGRG6	1.10e-03	1489	61	9	28611215
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	FLII USP6 MYO9A NTAQ1 LARS1 QARS1 SMAD9	1.15e-03	925	61	7	28986522
Pubmed	The protein interaction landscape of the human CMGC kinase group.	SFMBT1 AURKC PPP2R2A ZNF33A CLK2 PIP	1.36e-03	695	61	6	23602568
Pubmed	Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.	BMP3 KREMEN1	1.64e-03	34	61	2	23293290
Interaction	UGT2A3 interactions	NEK4 UGT2B15 ZRANB1	4.74e-07	6	59	3	int:UGT2A3
Cytoband	4q13	UGT2B15 UGT2B17	1.80e-04	15	61	2	4q13
Cytoband	8q24.13	NTAQ1 C8orf76	1.06e-03	36	61	2	8q24.13
Cytoband	17p11.2	TMEM11 FLII B9D1	1.27e-03	159	61	3	17p11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr8q24	ZFAT NTAQ1 C8orf76 NDUFB9	1.30e-03	355	61	4	chr8q24
Cytoband	3p21.1	NEK4 SFMBT1	1.44e-03	42	61	2	3p21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr7q34	CLEC5A PIP PRSS58	1.95e-03	185	61	3	chr7q34
Cytoband	Ensembl 112 genes in cytogenetic band chr17p11	TMEM11 FLII B9D1	2.54e-03	203	61	3	chr17p11
Cytoband	Ensembl 112 genes in cytogenetic band chr15q23	IQCH MYO9A	3.74e-03	68	61	2	chr15q23
Cytoband	Ensembl 112 genes in cytogenetic band chr22q12	KREMEN1 TBC1D10A TIMP3	3.83e-03	235	61	3	chr22q12
Cytoband	19q13.43	AURKC ZNF776	6.04e-03	87	61	2	19q13.43
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	NEK4 SFMBT1 QARS1	8.66e-03	316	61	3	chr3p21
GeneFamily	Aminoacyl tRNA synthetases, Class I	LARS1 QARS1	8.37e-04	19	41	2	131
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LYPD6 TIMP3 GPR173 VPS35L GDF10	3.85e-06	172	61	5	1bad7b19724e1b53ace7e05644215334c9f43910
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR83 FRAS1 TBC1D10A TIMP3 ADGRG6	7.83e-06	199	61	5	a76aa30fb264bdcbc0cb09113f814fc5a89e7319
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	1.18e-05	3	59	2	EFO_0800574
Disease	X-25937 measurement	UGT2B15 UGT2B17	2.35e-05	4	59	2	EFO_0800937
Disease	X-24574 measurement	UGT2B15 UGT2B17	8.20e-05	7	59	2	EFO_0800897
Disease	omega-3 polyunsaturated fatty acid measurement	LPA UGT2B15 UGT2B17 TMC4	9.33e-05	118	59	4	EFO_0010119
Disease	deoxycholic acid glucuronide measurement	UGT2B15 UGT2B17	1.09e-04	8	59	2	EFO_0800575
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	1.75e-04	10	59	2	EFO_0022090
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	2.14e-04	11	59	2	EFO_0801531
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	2.56e-04	12	59	2	EFO_0800291
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	3.02e-04	13	59	2	EFO_0800293
Disease	X-19141 measurement	UGT2B15 UGT2B17	3.02e-04	13	59	2	EFO_0800799
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	3.52e-04	14	59	2	EFO_0800283
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	NEK4 LPA UGT2B15 SYN2 UGT2B17	3.73e-04	307	59	5	EFO_0004612, EFO_0020946
Disease	high density lipoprotein particle size measurement	LPA UGT2B15 SYN2 UGT2B17	3.78e-04	170	59	4	EFO_0008592
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	LPA UGT2B15 SYN2 UGT2B17 LANCL1	4.20e-04	315	59	5	EFO_0004612, EFO_0008591
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	LPA UGT2B15 SYN2 UGT2B17 LANCL1	4.57e-04	321	59	5	EFO_0004612, EFO_0004639
Disease	lipid measurement, high density lipoprotein cholesterol measurement	LPA UGT2B15 SYN2 UGT2B17 LANCL1	5.18e-04	330	59	5	EFO_0004529, EFO_0004612
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	5.89e-04	18	59	2	EFO_0800288
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	6.58e-04	19	59	2	EFO_0800362
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	7.30e-04	20	59	2	EFO_0800317
Disease	Deep Vein Thrombosis	LPA F13A1	8.05e-04	21	59	2	C0149871
Disease	Venous Thrombosis	LPA F13A1	8.05e-04	21	59	2	C0042487
Disease	X-24947 measurement	UGT2B15 UGT2B17	8.85e-04	22	59	2	EFO_0800910
Disease	epiandrosterone sulfate measurement	UGT2B15 UGT2B17	1.14e-03	25	59	2	EFO_0021120
Disease	Ciliopathies	B9D1 RPE65 CEP164	1.41e-03	110	59	3	C4277690
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	LPA UGT2B15 SYN2 UGT2B17	1.43e-03	243	59	4	EFO_0004612, EFO_0020944
Disease	Child Development Disorders, Specific	ARFGAP1 CAMKMT	1.54e-03	29	59	2	C0085997
Disease	Child Development Deviations	ARFGAP1 CAMKMT	1.54e-03	29	59	2	C0085996
Disease	Developmental Disabilities	ARFGAP1 CAMKMT	1.65e-03	30	59	2	C0008073
Disease	Polydactyly	FRAS1 B9D1 CEP164	1.68e-03	117	59	3	C0152427
Disease	fatty acid measurement	NEK4 LPA UGT2B15 UGT2B17 TMC4	1.79e-03	436	59	5	EFO_0005110
Disease	androsterone sulfate measurement	UGT2B15 UGT2B17	1.99e-03	33	59	2	EFO_0021117

Protein segments in the cluster

Peptide	Gene	Start	Entry
EWIISPKSFDAYYCS	BMP3	386	P12645
KQQPWYCEVYQYSEC	ATP13A5	996	Q4VNC0
YDEKVDLWCIGVLCY	AURKC	216	Q9UQB9
LYENDCIFDKFECCW	PPP2R2A	336	P63151
YDCKWYIPLTDLSFQ	BCR	751	P11274
PCDVWSIGCIIFEYY	CLK2	361	P49760
EFCWIQDPVIFYVTC	ADGRG6	1011	Q86SQ4
EDYDPCWSLQEKYNS	ARFGAP1	91	Q8N6T3
PVTIWNSVYCCYDLA	ANKRD61	401	A6NGH8
TAFCDIPSYLKCYKW	IQCH	666	Q86VS3
YCAKLCEPQWFYEET	C8orf76	31	Q96K31
QDCYVFLCRYWVPVE	FLII	931	Q13045
YYLDFSTNTCKECDW	FRAS1	946	Q86XX4
EKYLCDAYQCADVIW	LANCL1	296	O43813
NEWIISPKSFDAYYC	GDF10	391	P55107
KPYNYKSDVWALGCC	NEK4	181	P51957
TYILFNPWCEDDAVY	F13A1	181	P00488
EDGVYWKYCEIPACQ	KREMEN1	101	Q96MU8
ATVRWDYQPDICKDY	RNF113A	191	O15541
SSTCYNPFIYCWLNE	GPR83	336	Q9NYM4
YLCPNDWLLNEGKCY	KLRF2	76	D3W0D1
NFIAPNKYEYCIWID	ELMO2	646	Q96JJ3
WCYTMNPRKLFDYCD	LPA	1781	P08519
SVPSQVYCECDKYWK	ATRNL1	226	Q5VV63
PYIVACYWRVFVKAC	GPR173	301	Q9NS66
ADNYECNRWAPDIYC	LYPD6	56	Q86Y78
GQWKYCQSEDYPRCI	ELSPBP1	61	Q96BH3
DDLYCKYCFVYGQDW	B9D1	26	Q9UPM9
CVYSSCYCEENIWKL	NTAQ1	21	Q96HA8
CYCEENIWKLCEYIK	NTAQ1	26	Q96HA8
WPYCEKRCSYCNFNK	RSAD1	46	Q9HA92
SYFWLCNALDVYCPV	QARS1	466	P47897
LESIYNFCDKPWVFA	SYN2	216	Q92777
VDLCCWKGFEFVYNY	RPE65	326	Q16518
YDVLSFYYCCLWAPD	SUSD2	411	Q9UGT4
STWSYNVCDIYKEPD	PRSS58	136	Q8IYP2
EELCSWYQSFLKDCP	RCVRN	26	P35243
ECVVALCDQWYLDYG	LARS1	521	Q9P2J5
YERYDCYKVPEWCLD	NDUFB9	91	Q9Y6M9
YTACLCDDNPKTFYW	PIP	86	P12273
EFWCKFYACCLQYQE	NUP160	526	Q12769
CYEEPQHWCSVAYYE	SMAD9	266	O15198
EWKPCQDITGDIYYF	CEP164	61	Q9UPV0
CIWPSEEVLAYYCLK	CAMKMT	126	Q7Z624
CPKDWEFYQARCFFL	CLEC5A	71	Q9NY25
TCCYVTTYKDQPYLW	C12orf29	61	Q8N999
CIYYPWELELSSFEN	SPATA4	86	Q8NEY3
VPEEEYWYCPSCKTD	UHRF2	381	Q96PU4
DLECEYCGKLFWYQV	ZFAT	741	Q9P243
DYINCAEVWVEYTCK	VPS35L	501	Q7Z3J2
WQFDPCCKYQVEYDA	TMEM11	126	P17152
CGYNYKQLPCWETVL	TMC4	466	Q7Z404
PSDQNCYDDSVYWKV	RHAG	391	Q02094
WKPYECYECGKTFCL	ZNF33A	521	Q06730
YPSQDFDWADYLKQC	SFMBT1	351	Q9UHJ3
LCWEYYDYSNKLCKD	UGT2B15	116	P54855
FWCLVQICEKYLPGY	TBC1D10A	216	Q9BXI6
PNCKWYCYNDSSCEE	USP6	1336	P35125
EYCTYENWPSAIKCT	ZRANB1	11	Q9UGI0
LCWEYSDYNIKLCED	UGT2B17	116	O75795
YYLPCFVTSKNECLW	TIMP3	151	P35625
KRPYQCGQCDESFWY	ZNF776	261	Q68DI1
WDDYCYDSEPDCFTV	MYO9A	376	B2RTY4